UNC Lineberger Comprehensive Cancer Center’s Angela B. Smith, MD, MS, FACS, has been named director of Urologic Oncology in the UNC Department of Urology and co-director of the Multidisciplinary Genitourinary Oncology Service at the N.C. Cancer Hospital, UNC Lineberger’s clinical home. Smith, who is a board-certified urologist who specializes in the treatment of bladder, prostate, … Continued
Tag: clinical research
Blistering sunburns, fair skin and a family history of skin cancer are known risk factors for developing melanoma, the deadliest form of skin cancer. A new study led by a University of North Carolina Lineberger Comprehensive Cancer Center researcher confirms that certain inherited genetic features are also linked to a person’s melanoma risk. In a … Continued
A pair of studies led by University of North Carolina Lineberger Comprehensive Cancer Center researchers could aid in improved diagnosis for melanoma, the deadliest form of skin cancer. The studies, led by UNC Lineberger’s Nancy Thomas, MD, PhD, Irene & Robert Alan Briggaman Distinguished Professor and Chair in the UNC School of Medicine Department of … Continued
UNC Lineberger’s Joshua Zeidner, MD, reported preliminary data at the 60th American Society of Hematology Annual Meeting from a phase II clinical trial for administering a high-dose of the chemotherapy treatment cytarabine followed by an immune checkpoint inhibitor, pembrolizumab, in patients with acute myeloid leukemia that had relapsed or no longer responded to other treatment.
There are many ways to show gratitude, but one patient took it to a new level, using her ties to the wedding industry and a tight-knit group of friends to hold an event to benefit ovarian cancer research and UNC Lineberger Comprehensive Cancer Center. With the help of her friends and daughter Terri Yates, Cindy … Continued
UNC Lineberger’s Bhishamjit S. Chera, MD, will present preliminary findings at the 60th Annual Meeting of the American Society for Radiation Oncology on Tuesday from a study that evaluated a blood test for HPV-linked oropharyngeal squamous cell carcinoma, which is a cancer of the back of the throat. The findings demonstrated the test could be an effective and less costly alternative for monitoring for cancer recurrence after radiation treatment.